Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors
RNA-seq (gene expression) · human · 61 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 61 samples: 17 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid TumorsMolecular cancer therapeutics · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE260599_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1082286 and SRA study SRP492609. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 51 samples read as cases, 7 as controls.
How we read this: 17 replicated groups read from 61 sample titles; they account for 49 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8120440 anti-PD-1 + control anti-KLH treatment at Week 4, mouse LOHM_a
- GSM8120441 anti-PD-1 + control anti-KLH treatment at Week 4, mouse KWM_a
- GSM8120442 anti-PD-1 + control anti-KLH treatment at Week 4, mouse LOHM_d
- GSM8120443 anti-PD-1 + anti-Lair1 treatment at Week 4, mouse WTSV_ai
- GSM8120444 anti-PD-1 + anti-Lair1 treatment at Week 4, mouse WTSV_ae
- GSM8120445 anti-PD-1 + anti-Lair1 treatment at Week 4, mouse WTSV_af
- GSM8120446 anti-PD-1 + anti-Lair1 treatment at Week 4, mouse WTSV_ah
- GSM8120447 control isotype antibody treatment on collagen from patient 20356, sample 55
- GSM8120448 control isotype antibody treatment on collagen from patient 30214, sample 47
- GSM8120449 control isotype antibody treatment on collagen from patient 20961, sample 51
- GSM8120450 47H1 treatment on collagen from patient 30214, sample 54 47H1 treatment on colla…
- GSM8120451 47H1 treatment on collagen from patient 20961, sample 50
- GSM8120452 47H1 treatment on collagen from patient 30214, sample 46 47H1 treatment on colla…
- GSM8120453 F140509 Gastric cancer stroma CD68+ ROI 1 F140509 Gastric cancer …
- GSM8120454 F140509 Gastric cancer stroma CD68- ROI 1 F140509 Gastric cancer …
- GSM8120455 F140509 Gastric cancer stroma CD68+ ROI 2 F140509 Gastric cancer …
- GSM8120456 F140509 Gastric cancer stroma CD68- ROI 2 F140509 Gastric cancer …
- GSM8120457 F140509 Gastric cancer stroma CD68+ ROI 3 F140509 Gastric cancer …
- GSM8120458 F140509 Gastric cancer stroma CD68- ROI 3 F140509 Gastric cancer …
- GSM8120459 F140509 Gastric cancer tumor nest CD68+ ROI 4 F140509 Gastric cancer …
- GSM8120460 F140509 Gastric cancer tumor nest CD68- ROI 4 F140509 Gastric cancer …
- GSM8120461 F140509 Gastric cancer tumor nest CD68+ ROI 5 F140509 Gastric cancer …
- GSM8120462 F140509 Gastric cancer tumor nest CD68- ROI 5 F140509 Gastric cancer …
- GSM8120463 F140509 Gastric cancer tumor nest CD68+ ROI 6 F140509 Gastric cancer …
- GSM8120464 F140509Gastric cancer tumor nest CD68- ROI 6
- GSM8120465 43728 Lung cancer stroma CD68+ ROI 1 43728 Lung cancer strom…
- GSM8120466 43728 Lung cancer stroma CD68- ROI 1 43728 Lung cancer strom…
- GSM8120467 43728 Lung cancer stroma CD68+ ROI 2 43728 Lung cancer strom…
- GSM8120468 43728 Lung cancer stroma CD68- ROI 2 43728 Lung cancer strom…
- GSM8120469 43728 Lung cancer stroma CD68+ ROI 3 43728 Lung cancer strom…
- GSM8120470 43728 Lung cancer stroma CD68- ROI 3 43728 Lung cancer strom…
- GSM8120471 43728 Lung cancer tumor nest CD68+ ROI 4 43728 Lung cancer tumor…
- GSM8120472 43728 Lung cancer tumor nest CD68- ROI 4 43728 Lung cancer tumor…
- GSM8120473 43728 Lung cancer tumor nest CD68+ ROI 5 43728 Lung cancer tumor…
- GSM8120474 43728 Lung cancer tumor nest CD68- ROI 5 43728 Lung cancer tumor…
- GSM8120475 43728 Lung cancer tumor nest CD68+ ROI 6 43728 Lung cancer tumor…
- GSM8120476 43728 Lung cancer tumor nest CD68- ROI 6 43728 Lung cancer tumor…
- GSM8120477 43881 Lung cancer stroma CD68+ ROI 1 43881 Lung cancer strom…
- GSM8120478 43881 Lung cancer stroma CD68- ROI 1 43881 Lung cancer strom…
- GSM8120479 43881 Lung cancer stroma CD68+ ROI 2 43881 Lung cancer strom…
+ 21 more — browse all 61 samples with per-sample file links →
- GSE315130 Differential mRNA expression analysis of multiple human and mouse pancreatic cancer cells and tumors after DMSO, tazemetostat, RMC-6236, or the combination treatment. 67 samples shares combination, treat
- GSE301188 Envafolimab and Chidamide in combination with GEMOX as first-line treatment for advanced and metastatic biliary tract cancer (B-Enefits/SCOG-B001): A single-arm, exploratory, phase 2 trial 6 samples shares combination, treat
- GSE266919 Distinct Cellular Mechanisms Underlie Chemotherapies and Their Combinations with PD-L1 Checkpoint Inhibitor in Triple-Negative Breast Cancer [TNBC] 117 samples shares combination
- GSE255972 The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models 64 samples shares combination
- GSE317309 Combination of a CCL21-gene modified dendritic cell vaccine and pembrolizumab induces immune responses in non-small cell lung cancer 64 samples shares combination
- GSE251918 Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations [RNA-seq] 8 samples shares combination
- GSE313963 Transposase-assisted in situ capture of recombination DSB hotspots (TAID-seq) [CUT&Tag] 45 samples shares combination
- GSE251920 Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations 18 samples shares combination
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.